Treatment administered over video on a smartphone is more likely to be adhered by tuberculosis (TB) patients than through face-to-face appointments, finds a study.
Directly observed treatment (DOT) has been the standard of care for TB since the early 1990s, but it is inconvenient for patients and service providers.
Drug-Resistant Tuberculosis
Drug-resistant tuberculosis (TB) is a globally serious infectious disease caused by the bacterium Mycobacterium tuberculosis. It occurs as multidrug-resistant or MDR TB or in its more severe form, extensively drug-resistant or XDR TB.
Advertisement
‘The smartphone-enabled video-observed therapy (VOT) supported daily dosing, had lower dropouts and was also useful for socially complex populations.’
Tweet it Now
The smartphone-enabled video-observed therapy (VOT), recommended by the World Health Organization as an alternative to DOT, is a more effective approach to TB treatment, stated the study published in The Lancet.
"VOT is likely to be preferable for many patients across a broad range of settings, providing a more acceptable, effective, cheaper option for supervision of multiple daily doses than DOT," said Andrew C. Hayward from the University College London.
![Extra Pulmonary Tuberculosis]( "Extra Pulmonary Tuberculosis")
Extra pulmonary tuberculosis is infection of tissues and organs other than the lungs by mycobacterium tuberculosis and related organisms.
The study tested whether levels of treatment observation were improved with VOT. The team randomly assigned 226 patients -- 112 to VOT and 114 to DOT.
Seventy eight of 112 patients on VOT achieved 80 per cent scheduled observations successfully completed during the first two months compared with 35 of 114 on DOT.
VOT also supported daily dosing, was effective for socially complex populations and had a lower drop-out rate than DOT.
The absence of face-to-face contact did not reduce the identification of adverse events or lead to more unscheduled appointments. VOT reduced staff time requirements, especially compared with home-based DOT, the study showed.
"There is an urgent global need for more effective and cheaper alternatives to DOT to enable effective ambulatory care of both drug-sensitive and MDR TB," Hayward said.
According to the US Centers for Disease Control and Prevention (CDC), TB is one of the world's deadliest diseases.
In 2017, 10 million people around the world became sick with TB disease. There were 1.3 million TB-related deaths worldwide. It is also a leading killer of people who are HIV infected.
Source: IANS
Extra Pulmonary Tuberculosis
Extra pulmonary tuberculosis is infection of tissues and organs other than the lungs by mycobacterium tuberculosis and related organisms.
Advertisement
The study tested whether levels of treatment observation were improved with VOT. The team randomly assigned 226 patients -- 112 to VOT and 114 to DOT.
Seventy eight of 112 patients on VOT achieved 80 per cent scheduled observations successfully completed during the first two months compared with 35 of 114 on DOT.
VOT also supported daily dosing, was effective for socially complex populations and had a lower drop-out rate than DOT.
The absence of face-to-face contact did not reduce the identification of adverse events or lead to more unscheduled appointments. VOT reduced staff time requirements, especially compared with home-based DOT, the study showed.
"There is an urgent global need for more effective and cheaper alternatives to DOT to enable effective ambulatory care of both drug-sensitive and MDR TB," Hayward said.
According to the US Centers for Disease Control and Prevention (CDC), TB is one of the world's deadliest diseases.
In 2017, 10 million people around the world became sick with TB disease. There were 1.3 million TB-related deaths worldwide. It is also a leading killer of people who are HIV infected.
Source: IANS
Renal Tuberculosis
Renal tuberculosis or tuberculosis of the kidney is a type of genitourinary tuberculosis that can be treated with anti-tubercular medications.
Advertisement
 Screening Tests for TuberculosisTuberculin skin test and Interferon - Release Assays are tests used to screen for tuberculosis. | Advertisement
|
Advertisement
Recommended Readings
Latest Medical Gadgets
Apart from monitoring basic health, the new apple watch series 9 features a new double tap gesture to control apps without touching the watch.
Our artificial olfactory system combines sensing and processing efficiently, mirroring the biological olfactory system's function for energy and space savings.
A portable, lightweight, and affordable exoskeleton designed for stroke patients promises expanded accessibility, particularly in areas with limited resources.
A textile-based wearable device that 'taps' a user's wrist with pressurized air, silently guides the person finding their way to their destination.
A device controlled through a mobile app, utilizing heat signatures and bacterial fluorescence, helps detect and address infections in wounds.
